Papers

2

Total Citations

35

H-Index

2

About

Dr. Hiroya Hashimoto is a pioneering surgeon whose work bridges anesthesiology and urological oncology, with a focus on optimizing perioperative outcomes through innovative imaging and airway management. His most cited study, a randomized controlled trial from 2023 (32 citations), demonstrated that the combined use of the ProSeal laryngeal mask airway and a bronchial blocker is a safe, effective alternative to double-lumen endobronchial tubes in thoracoscopic surgery—a finding that has influenced clinical protocols for lung isolation. In urology, Dr. Hashimoto has advanced robot-assisted partial nephrectomy (RAPN) by introducing a three-dimensional computed tomography-based resection process map (RPM). His 2024 retrospective study (3 citations) showed that preoperative RPM imaging significantly improves surgical precision and renal function preservation, as validated through propensity score matching. This work underscores his commitment to integrating digital anatomy into minimally invasive surgery. With a career marked by rigorous trial design and translational impact, Dr. Hashimoto’s contributions are shaping safer, more personalized surgical care.

Research Focus

Key Achievements

2
H-Index
2
Papers
35
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Combined use of the ProSeal laryngeal mask airway and a bronchial blocker vs. a double-lumen endobronchial tube in thoracoscopic surgery: A randomized controlled trial
32 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Nagoya City University Hospital, National Hospital Organization

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago